Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Saphenous vein graft interventions.

Brilakis ES, Lee M, Mehilli J, Marmagkiolis K, Rodes-Cabau J, Sachdeva R, Kotsia A, Christopoulos G, Rangan BV, Mohammed A, Banerjee S.

Curr Treat Options Cardiovasc Med. 2014 May;16(5):301. doi: 10.1007/s11936-014-0301-x.

PMID:
24643432
2.

Percutaneous intervention of acutely occluded saphenous vein grafts: contemporary techniques and outcomes.

Abdel-Karim AR, Banerjee S, Brilakis ES.

J Invasive Cardiol. 2010 Jun;22(6):253-7.

3.

In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry.

Tolerico PH, Cohen DJ, Kleiman NS, Berger PB, Brilakis ES, Piana RN, Shammo S, Keyes MJ, Kennedy KF, Massaro JM, Saucedo JF; EVENT Investigators.

Catheter Cardiovasc Interv. 2012 Dec 1;80(7):1127-36. doi: 10.1002/ccd.24352. Epub 2012 May 4.

PMID:
22431166
4.

Initial clinical experience with distal protection using the FilterWire in patients undergoing coronary artery and saphenous vein graft percutaneous intervention.

Popma JJ, Cox N, Hauptmann KE, Reifart N, Virmani R, Emira K, Murphy S, Gibson CM, Grube E.

Catheter Cardiovasc Interv. 2002 Oct;57(2):125-34.

PMID:
12357506
5.

Impact of diabetes on five-year outcomes after vein graft interventions performed prior to the drug-eluting stent era.

Ashfaq S, Ghazzal Z, Douglas JS, Morris DC, Veledar E, Weintraub WS.

J Invasive Cardiol. 2006 Mar;18(3):100-5.

PMID:
16598106
6.

Failure of the Symbiot PTFE-covered stent to reduce distal embolization during percutaneous coronary intervention in saphenous vein grafts.

Blackman DJ, Choudhury RP, Banning AP, Channon KM.

J Invasive Cardiol. 2005 Nov;17(11):609-12.

PMID:
16264208
7.

Embolic Protection Devices for Saphenous Vein Graft Percutaneous Coronary Interventions.

Foley JD 3rd, Ziada KM.

Interv Cardiol Clin. 2013 Apr;2(2):259-271. doi: 10.1016/j.iccl.2012.11.008. Epub 2013 Feb 12. Review.

PMID:
28582134
8.

Poor long-term patient and graft survival after primary percutaneous coronary intervention for acute myocardial infarction due to saphenous vein graft occlusion.

Brodie BR, VerSteeg DS, Brodie MM, Hansen C, Richter SJ, Stuckey TD, Gupta N, Pulsipher M, Downey W.

Catheter Cardiovasc Interv. 2005 Aug;65(4):504-9.

PMID:
15988742
9.

Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era.

Pucelikova T, Mehran R, Kirtane AJ, Kim YH, Fahy M, Weisz G, Lansky AJ, Moussa I, Gray WA, Collins MB, Kodali SK, Stone GW, Moses JW, Leon MB, Dangas G.

Am J Cardiol. 2008 Jan 1;101(1):63-8. Epub 2007 Nov 19.

PMID:
18157967
10.

Procedural results and distal embolization after saphenous vein graft stenting and angioplasty for in-stent restenosis of grafts.

Cicek D, Doven O, Pekdemir H, Camsari A, Akkus NM, Cin GV, Parmaksiz T, Katircibasi T.

Jpn Heart J. 2004 Jul;45(4):561-71.

11.

Percutaneous saphenous vein graft interventions with and without distal filter wire protection.

Hofmann M, Störger H, Schwarz F, Schwarz CE, Reinemer H, Ruef J, Schöpf J, Haase J.

J Interv Cardiol. 2005 Dec;18(6):475-9.

PMID:
16336428
12.

Paclitaxel-Eluting Stents for Chronically Occluded Saphenous Vein Grafts (EOS) Study.

Jim MH, Ho HH, Ko RL, Siu CW, Yiu KH, Lau CP, Chow WH.

J Interv Cardiol. 2010 Jan 7. [Epub ahead of print]

PMID:
20070476
13.

Saphenous vein graft interventions: strategies and devices to minimize distal embolization.

Gaglia MA Jr, Pichard AD, Waksman R.

Minerva Cardioangiol. 2012 Apr;60(2):157-66. Review.

PMID:
22495164
14.

A comparison of drug-eluting stents versus bare metal stents in saphenous vein graft PCI outcomes: a meta-analysis.

Mamas MA, Foley J, Nair S, Wiper A, Clarke B, El-Omar M, Fraser DG, Khattar R, Neyses L, Fath-Ordoubadi F.

J Interv Cardiol. 2011 Apr;24(2):172-80. doi: 10.1111/j.1540-8183.2010.00620.x. Epub 2011 Jan 31.

PMID:
21281356
15.

Embolization after percutaneous coronary intervention in acute coronary syndrome. Saphenous vein grafts versus native coronary arteries.

Karakyriou M, Hadjimiltiades S, Meditskou S, Nenopoulou E, Efthimiadis G, Vogazianos P, Karvounis C, Styliadis I.

Herz. 2015 Mar;40 Suppl 1:36-42. doi: 10.1007/s00059-014-4184-0. Epub 2014 Dec 5.

PMID:
25471205
16.

Percutaneous saphenous vein graft intervention--a review.

Hiscock M, Oqueli E, Dick R.

Heart Lung Circ. 2007;16 Suppl 3:S51-5. Epub 2007 Jul 2. Review.

PMID:
17606404
17.

Long-term clinical benefit of sirolimus-eluting stents compared to bare metal stents in the treatment of saphenous vein graft disease.

Minutello RM, Bhagan S, Sharma A, Slotwiner AJ, Feldman DN, Cuomo LJ, Wong SC.

J Interv Cardiol. 2007 Dec;20(6):458-65.

PMID:
18042050
18.

Distal embolic protection for SVG interventions: can we afford not to use it?

Shaia N, Heuser RR.

J Interv Cardiol. 2005 Dec;18(6):481-4.

PMID:
16336429
19.

Embolic protection devices in saphenous vein graft interventions.

Cragun DT, Heuser RR.

J Interv Cardiol. 2006 Dec;19(6):525-9. Review.

PMID:
17107367
20.

Embolic protection device use and outcomes in patients receiving saphenous vein graft interventions--a single-center experience.

Golwala H, Hawkins BM, Stavrakis S, Abu-Fadel MS.

J Invasive Cardiol. 2012 Jan;24(1):1-3.

Supplemental Content

Support Center